NCT06681142 Pharmacist-physiotherapist Collaborative Management for Early Knee Osteoarthritis
| NCT ID | NCT06681142 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Alberta |
| Condition | Osteoarthritis (OA) of the Knee |
| Study Type | INTERVENTIONAL |
| Enrollment | 125 participants |
| Start Date | 2025-08-13 |
| Primary Completion | 2026-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 125 participants in total. It began in 2025-08-13 with a primary completion date of 2026-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Osteoarthritis (OA) is a slowly progressive chronic condition that is associated with aging and is characterized as joint pain. Individuals with early-stage OA usually do not seek medical attention. If and when they do, patients more often present to a pharmacy for over-the-counter medications. The investigators want to leverage community pharmacists' accessibility and scope of practice to best support patients with early knee OA. Given there are no disease-modifying treatments for OA, treatment guidelines center on patient education, self-management, and exercise, with medications playing a supporting role. Self-management is an effective strategy that provides a solid foundation for managing this progressive chronic condition and health care professionals like physiotherapists and pharmacists can help with the development and application of these skills.
Eligibility Criteria
Inclusion Criteria: * regularly experiencing pain, aching, or stiffness in and/or around the knee for at least 1 month * complete the screening PhIT-OA questionnaire Exclusion Criteria: * prior knee surgery * history of acute knee injury (6 months) * unable or unwilling to attend physiotherapy * previous physician diagnoses of inflammatory arthritis or fibromyalgia * unable to speak/ read English
Contact & Investigator
Ross Tsuyuki
PRINCIPAL INVESTIGATOR
University of Alberta
Frequently Asked Questions
Who can join the NCT06681142 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, studying Osteoarthritis (OA) of the Knee. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06681142 currently recruiting?
Yes, NCT06681142 is actively recruiting participants. Contact the research team at cajones@ualberta.ca for enrollment information.
Where is the NCT06681142 trial being conducted?
This trial is being conducted at Sherwood Park, Canada.
Who is sponsoring the NCT06681142 clinical trial?
NCT06681142 is sponsored by University of Alberta. The principal investigator is Ross Tsuyuki at University of Alberta. The trial plans to enroll 125 participants.